Compara mètodes

	Monitor Breu de Addiccions (BAM)	Test de Detecció del Trastorn per Ús de Cànnabis	Eina d'avaluació del risc d'opioides (ORT)
Camp	Medicina de les addiccions	Medicina de les addiccions	Medicina de les addiccions
Família	Process / pipeline	Process / pipeline	Process / pipeline
Any d'origen	2013	2010	2005
Autor original	Cacciola, Alterman, Drapkin, Valadez	Adamson, Kay-Lambkin, Baker, Lewin, Thornton, Kelly, Sellman	Webster, Webster
Tipus	Self-report	Self-report	Self-report
Font seminal	Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263.	Adamson, S. J., Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., Thornton, L., Kelly, B. J., & Sellman, J. D. (2010). An improved brief screening instrument for cannabis use disorder. Drug and Alcohol Dependence, 110(1–2), 55–60.	Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Medicine, 6(6), 432–442.
Àlies	BAM	CUDIT-R, CUDIT	ORT
Relacionats	4	4	4
Resum	The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care.	The CUDIT-R is a brief, 8-item self-report screening instrument developed to identify cannabis use disorder and hazardous cannabis use patterns. Introduced by Adamson and colleagues in 2010 as a revision of the original CUDIT, the CUDIT-R improves brevity and screening efficiency while maintaining strong psychometric properties. It is designed for use in primary care, addiction treatment, and public health settings to detect problematic cannabis use and inform treatment allocation decisions.	The ORT is a brief, 10-item self-report screening instrument designed to identify patients at elevated risk for opioid misuse, addiction, or aberrant drug-related behaviors prior to initiating opioid therapy. Developed by Webster and Webster in 2005, it stratifies patients into low, moderate, and high risk categories based on personal and family history of substance abuse, psychiatric comorbidity, and psychosocial factors. The ORT is widely used in pain management and primary care settings to guide shared decision-making and risk mitigation strategies when prescribing opioids.